as49jt2x | Knowledge4COVID-19

Property	Value
?:abstract	To expand testing capacity during the SARS-CoV-2 pandemic, numerous molecular assays have been granted emergency use authorization (EUA) for testing individual patient samples but not for sample pooling. .
?:creator	<https://research.tib.eu/covid-19/entity/Mitchell%2C_Stephanie_L%3B_Ventura%2C_Samantha_E>
?:journal	J._clin._microbiol
?:license	unk
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/COVID-19>
?:source	WHO
?:title	Evaluation and Comparison of the Hologic Aptima SARS-CoV-2 and the CDC 2019 nCoV real-time RT-PCR Diagnostic Panel using a Four-Sample Pooling Approach
?:type	<https://research.tib.eu/covid-19/vocab/Publication>
?:who_covidence_id	#781090
?:year	2020

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/as49jt2x>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/as49jt2x>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all